Cold-Chain Provider Shanghai Shengsheng Renews Hong Kong Listing Plan
China’s biggest supplier of temperature-controlled services for the drug sector has renewed a Hong Kong listing plan, raising questions with hefty pre-IPO payouts image credit: Bamboo Works Key
A big Chinese company that keeps medicine cold is trying to sell shares on the Hong Kong stock market again. Watch whether they're making smart decisions with their money, since they've been paying out a lot before this listing.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.